Trump signs order to use AI to accelerate pediatric cancer research

Anthony Letai sworn in as 18th NCI director

Anthony G. Letai, accompanied by his wife Jean, was sworn in by HHS Secretary Kennedy as the 18th NCI Director on Sept. 29.Anthony G. Letai, a physician-scientist at Harvard Medical School and Dana-Farber Cancer Institute, has been officially named the 18th director of the National Cancer Institute.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Capitol Hill

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

On Oct. 1, for the first time in six years, the U.S. government shut down after Congress was unable to reach a deal to fund federal agencies for Fiscal Year 2026.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

Cancer Policy

White House announces “TrumpRx,” a new prescription drug website

President Donald Trump has announced a multipronged effort aimed at lowering drug costs in the United States, including the creation of “TrumpRx,” a direct-to-consumer website where Americans can buy medicine at discounted prices and a sweeping deal with Pfizer to reduce the prices of many of its products.

October 03, 2025

Vol.51 No.36

By Claire Marie Porter

In Brief

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

The University of Cincinnati Cancer Center’s Joan Garrett has received a two-year, $162,000 NCI grant to study a new combination approach to treat KRAS-mutated colorectal cancers.

October 03, 2025

Vol.51 No.36

Podcast

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown

With little fanfare, Anthony Letai, a highly respected physician-scientist, was sworn in as the 18th director of the National Cancer Institute on Sept. 29. Then, two days later, on Oct. 1, the government shut down.

October 01, 2025

Guest Editorial

Population-based cancer surveillance is a national treasure at risk

There is a silent crisis in cancer research that underpins nearly all aspects of the work we do to combat this disease.

September 26, 2025

Vol.51 No.35

By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash

Trump signs order to use AI to accelerate pediatric cancer research

YOU MAY BE INTERESTED IN

Anthony Letai sworn in as 18th NCI director

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs

White House announces “TrumpRx,” a new prescription drug website

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown

Population-based cancer surveillance is a national treasure at risk

Renew today!

Subscriber content

Never miss an issue!

Login

Trump signs order to use AI to accelerate pediatric cancer research

YOU MAY BE INTERESTED IN

Anthony Letai sworn in as 18th NCI director

U.S. government shuts downImpact on NCI uncertain as administration threatens more RIFs

White House announces “TrumpRx,” a new prescription drug website

The University of Cincinnati researchers win NCI grant to study combination colorectal cancer treatment

With Anthony Letai’s appointment, NCI is now under new leadership—just in time for a shutdown

Population-based cancer surveillance is a national treasure at risk

Never miss an issue!

Login

U.S. government shuts down
Impact on NCI uncertain as administration threatens more RIFs